SEC FORM 4
$855,205.20
TAKEDA PHARMACEUTICAL CO LTD (TAK)
Sale of 50,012 shares at $17.10 per share.
Reporting Person Bitetti Teresa Marie · Officer Title President, OBU · Transaction Code S
Traded Aug 10, 2026 · Disclosed Aug 12, 2026
Source: SEC Form 4 · 0001493152-26-037502 · filed 2026-08-12 · View filing →